DARE (Dare Bioscience) OCF Margin %: -3,632.24% (As of Mar. 2026)

What is Dare Bioscience OCF Margin %?

Dare Bioscience DARE +2.25% 23 OCF Margin % is -3,632.24% as of Mar. 2026. GuruFocus rates DARE with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Dare Bioscience ranks worse than 78.62% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Dare Bioscience's Cash Flow from Operations for the three months ended in Mar. 2026 was $-5.52 Mil. Dare Bioscience's Revenue for the three months ended in Mar. 2026 was $0.15 Mil. Therefore, Dare Bioscience's OCF Margin % for the quarter that ended in Mar. 2026 was -3,632.24%.

As of today, Dare Bioscience's current OCF Yield % is -32.44%.

The historical rank and industry rank for Dare Bioscience's OCF Margin % or its related term are showing as below:

DARE' s OCF Margin % Range Over the Past 10 Years
Min: -1383.8 Med: -570.35 Max: 54740
Current: -858.77

During the past 13 years, the highest OCF Margin % of Dare Bioscience was 54740.00%. The lowest was -1383.80%. And the median was -570.35%.

DARE's OCF Margin % is ranked worse than
78.62% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs DARE: -858.77

Dare Bioscience OCF Margin % Related Terms

Dare Bioscience OCF Margin % Historical Data

* Premium members only.

The historical data trend for Dare Bioscience's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dare Bioscience OCF Margin % Chart

Dare Bioscience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

-180.88

-1,383.80

54,740.00

-959.81

Dare Bioscience Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-21,884.00	25,795.24	-22,100.00	141.02	-3,632.24

DARE vs TVGN, LITS, BOLD: OCF Margin % Comparison

For the Biotechnology subindustry, Dare Bioscience's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dare Bioscience OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's OCF Margin % falls into.

Save Embed

23GF Score

Dare Bioscience Inc DARE

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Dare Bioscience OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Dare Bioscience's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-9.886	/	1.03
	=	-959.81 %

Dare Bioscience's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-5.521	/	0.152
	=	-3,632.24 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -3,632.24% mean?

Dare Bioscience (DARE) has a OCF Margin % of -3,632.24% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Dare Bioscience and its competitors. According to the industry distribution chart, Dare Bioscience ranks #754 out of 959 companies in the Biotechnology industry, placing it in the top 78.6%.

Is Dare Bioscience's OCF Margin % too high?

Dare Bioscience's current OCF Margin % is -3,632.24%. Based on the distribution chart, Dare Bioscience ranks #754 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Dare Bioscience has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.

How does Dare Bioscience's OCF Margin % compare to TVGN and LITS?

According to the Biotechnology industry distribution chart, Dare Bioscience ranks #754 out of 959 companies for OCF Margin %. This places Dare Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Dare Bioscience and its competitors. Dare Bioscience's current OCF Margin % is -3,632.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Dare Bioscience stock overvalued right now?

Dare Bioscience (DARE) has a current OCF Margin % of -3,632.24%. The current OCF Margin % is -3,632.24%. Dare Bioscience's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Dare Bioscience (DARE), the current OCF Margin % is -3,632.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Industry Healthcare Biotechnology

Comparable Companies TVGN LITS BOLD PLRZ ALGS TVRD APLM ABVC GRDX INMB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122

Website https://www.darebioscience.com

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

23GF Score

Get the complete analysis for DARE

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.05

Price

View DARE Analysis

See OCF Margin % data for all stocks →